Matsunaga, Kazuto http://orcid.org/0000-0002-0514-3241
Adachi, Mitsuru
Nagase, Hiroyuki http://orcid.org/0000-0002-0296-5901
Okoba, Tomoko
Hayashi, Nobuya
Tohda, Yuji
Funding for this research was provided by:
AstraZeneca K.K., Osaka, Japan
Article History
Received: 22 February 2020
Accepted: 18 June 2020
First Online: 4 August 2020
Competing interests
: K.M. reports receipt of personal fees (honoraria) from Astellas Pharma Inc., Kyorin Pharmaceutical Co., Ltd., Novartis Pharma K.K., Nippon Boehringer Ingelheim Co., Ltd., and AstraZeneca K.K., outside the submitted work. M.A. reports receipt of personal fees (honoraria) from Toa Pharmaceuticals Co., Ltd., Kyowa Kirin Co., Ltd., Astellas Pharma Inc., AstraZeneca K.K., GlaxoSmithKline K.K., Kyorin Pharmaceutical Co., Ltd., MSD K.K., and Nippon Boehringer Ingelheim Co., Ltd., outside the submitted work. H.N. reports receipt of personal fees (honoraria) from AstraZeneca K.K., Nippon Boehringer Ingelheim Co., Ltd., Novartis Pharma, and Kyorin Pharmaceutical Co., Ltd., outside the submitted work. Y.T. reports receipt of personal fees (honoraria) from AstraZeneca K.K., Nippon Boehringer Ingelheim, Kyorin Pharmaceutical, and Meiji Seika Pharma, outside the submitted work. T.O. and N.H. are full-time employees of AstraZeneca K.K.